(1263) Assessment of the Economic Impact of Long-acting Injectable Administration by Pharmacists in a Community Pharmacy Setting

Objectives: The primary objective of this study is to identify the economic impact of pharmacists administering long-acting injectables (LAIs) in a community pharmacy setting. The secondary objective is to assess patient satisfaction with the community pharmacy service as compared to other sites that administer LAIs.

Methods: A prospective research design with purposive sampling will be utilized. An electronic Qualtrics® survey will be distributed to patients via a QR code at their LAI administration appointments in community pharmacies in Arizona through November 2023 to February 2024. The Economical, Clinical and Humanistic Outcomes (ECHO) and Pharmaceutical Care model will be utilized to guide how to collect patient data in an efficient and confidential manner. Inclusion criteria includes patients aged 18 or older receiving LAI administration by a pharmacist in the community pharmacy setting within this timeframe. Exclusion criteria will include patients under 18 years old, those that have not received the LAI administration from another practice site, or the first LAI in their lifetime. The survey will assess patient demographics such as gender, age, ethnicity, marital status, and yearly income. Patient satisfaction with the service will also be assessed in relation to areas such as efficiency with the service, comfortability of the pharmacist providing the service, and likelihood of the patient to recommend the service to someone else. Lastly, economic data related to the patient will be assessed with regards to cost of the service compared to other practice sites as well as proximity of the service compared to other sites they may have received it such as a primary care provider office6. Economic data includes cost savings provided to the patient through the service based on things such as patient income, patient proximity to service, and patient payments for the medication and service. Descriptive statistics such as a chi-squared test will be used to analyze and summarize data collected and the frequency of responses for each survey question.

Results: Results are still pending. Midwestern University IRB will review study for approval.

Conclusions: We hope to observe that patients do receive economic benefit from having pharmacists administer long-acting injectables in a community pharmacy setting. Patient comfortability with pharmacists to provide this service will also be taken into account.